Developing new compounds requires accurate, high-quality
data. Assay development and validation are critical steps in
drug discovery, ensuring your results are robust, reproducible,
and regulatory-compliant. Whether you’re a startup seeking
cost-effective solutions or a pharma company scaling complex workflows, we provide the expertise to move your science forward.
Assay development is the process of designing and optimising tests that measure biological activity, compound potency, or target engagement. A well-developed assay provides the foundation for screening, lead optimisation, and decision-making throughout the drug development pipeline.
Validation confirms that your assay performs consistently and accurately under defined conditions. It reduces risk, supports your discovery and development goals, and progresses through regulatory submissions, ensuring confidence in your data.
Our validation protocols align with FDA and EMA guidelines, providing high quality, reproducible data throughout all clinical phases , allowing your teams to continue with data analysis progressing your clinical trial.
Cell-based, Immunology, Serology, Enzyme, ELISA, Multiplexed binding, Molecular Biology, Drug Potency
ELISA, MSD, ELISpot, ddPCR QX700, Multiplex Cytokine Profiling MSD, NGS Illumina and DRAGEN pipeline, ddPCR, CTL Bacterial colony counter
Tailored solutions for unique targets and modalities
GCLP, GLP-compliant, assays validated to ICH guidelines
Cost-effective, rapid development to accelerate proof-of-concept
Scalable biotech assay solutions for growing pipelines
High-throughput, validated assays for global compliance
Our in-house team of cross-functional experts including consultancy, science, and laboratory operations will work with you on:
Consultation & Design aspects
Optimisation & Development
Validation & Documentation
Ongoing Support
Sign up to our emails and follow us on social media to keep up to date with hVIVO.
